Home/Filings/4/0001104659-22-063962
4//SEC Filing

El-Gabry Ehab 4

Accession 0001104659-22-063962

CIK 0001711933other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 6:15 PM ET

Size

5.4 KB

Accession

0001104659-22-063962

Insider Transaction Report

Form 4
Period: 2022-05-19
El-Gabry Ehab
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-05-19+150,000150,000 total
    Exercise: $9.47Exp: 2032-05-19Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]Subject to the reporting person's continuing service, the options shall vest as follows: twenty-five percent (25%) shall have vested on April 11, 2023 with the remainder vesting in 36 equal monthly installments beginning on April 11, 2023.

Issuer

Akoya Biosciences, Inc.

CIK 0001711933

Entity typeother

Related Parties

1
  • filerCIK 0001923169

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 6:15 PM ET
Size
5.4 KB